Journal of Vascular Surgery
Volume 49, Issue 5 , Pages 1172-1180.e1 , May 2009

Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization

Presented at the Peripheral Vascular Surgical Society Spring Meeting June, 2008, San Diego, Calif.

Received 13 July 2008 ,Accepted 3 December 2008.

  • Image Result

    Freedom from major adverse events (MAE). Two hundred five (32%) No-MetS and 116 (41%) MetS patients experienced a MAE (stroke, MI, or death) during follow-up, (P < .05). The 3-year freedom from MAE ra

    Freedom from major adverse events (MAE). Two hundred five (32%) No-MetS and 116 (41%) MetS patients experienced a MAE (stroke, MI, or death) during follow-up, (P < .05). The 3-year freedom from MAE rates were 42% and 32% for MetS and No-MetS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the Fig.

  • Image Result
    Freedom from stroke. Twenty-seven (4%) No-MetS and 23 (8%) No-MetS patients experienced a stroke during follow-up, (P < .05). The 3-year freedom from stroke rates were 93% and 96% for MetS and No-MetS

    Freedom from stroke. Twenty-seven (4%) No-MetS and 23 (8%) No-MetS patients experienced a stroke during follow-up, (P < .05). The 3-year freedom from stroke rates were 93% and 96% for MetS and No-MetS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the Fig.

  • Image Result
    Freedom from myocardial infarction (MI). Thirty-four (5%) No-MetS and 55 (19%) MetS patients experienced an MI during follow-up, (P < .05). The 3-year freedom from MI rates were 88% and 96% for MetS a

    Freedom from myocardial infarction (MI). Thirty-four (5%) No-MetS and 55 (19%) MetS patients experienced an MI during follow-up, (P < .05). The 3-year freedom from MI rates were 88% and 96% for MetS and No-MetS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the fig.

  • Image Result
    Survival. Four hundred sixty-one (72%) No-MetS and 201 (71%) MetS patients survived during follow-up, (P = NS). the 3-year survival rates were 84% and 87% for MetS and No-MetS, respectively. Error bar

    Survival. Four hundred sixty-one (72%) No-MetS and 201 (71%) MetS patients survived during follow-up, (P = NS). the 3-year survival rates were 84% and 87% for MetS and No-MetS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the Fig.

  • Image Result
    Freedom from restenosis. The 3-year freedom from restenosis rates were 84% and 70% for patients undergoing CEA and CAS, respectively. Error bars are omitted for clarity. Standard error did not exceed

    Freedom from restenosis. The 3-year freedom from restenosis rates were 84% and 70% for patients undergoing CEA and CAS, respectively. Error bars are omitted for clarity. Standard error did not exceed 10% at all time intervals that were analyzed. The number of patients at risk at each time interval is shown below the Fig.

 Competition of interest: none.

 Additional material for this article may be found online at www.jvascsurg.org.

PII: S0741-5214(08)02154-X

doi: 10.1016/j.jvs.2008.12.011

Journal of Vascular Surgery
Volume 49, Issue 5 , Pages 1172-1180.e1 , May 2009

Article Tools

* Image Usage & Resolution